Patients with Pelvic Floor Muscle Spasm Have a Superior Response to Pelvic Floor Physical Therapy at Specialized Centers
2015; Lippincott Williams & Wilkins; Volume: 194; Issue: 4 Linguagem: Inglês
10.1016/j.juro.2015.03.130
ISSN1527-3792
AutoresA. Scott Polackwich, Jianbo Li, Daniel A. Shoskes,
Tópico(s)Sexual function and dysfunction studies
ResumoNo AccessJournal of UrologyAdult Urology1 Oct 2015Patients with Pelvic Floor Muscle Spasm Have a Superior Response to Pelvic Floor Physical Therapy at Specialized Centers Alan Scott Polackwich, Jianbo Li, and Daniel A. Shoskes Alan Scott PolackwichAlan Scott Polackwich , Jianbo LiJianbo Li , and Daniel A. ShoskesDaniel A. Shoskes View All Author Informationhttps://doi.org/10.1016/j.juro.2015.03.130AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: Chronic prostatitis/chronic pelvic pain syndrome is a common condition that often requires multimodal therapy. Patients with chronic pelvic pain syndrome have a high incidence of pelvic floor spasm, which can be treated with pelvic floor physical therapy. However, this is a specialized skill. We compared outcomes of pelvic floor physical therapy as part of multimodal therapy in patients with chronic pelvic pain syndrome between those treated at our institution and elsewhere. Materials and Methods: We identified patients from our chronic pelvic pain syndrome registry with pelvic floor spasm who were seen between 2010 and 2014 for more than 1 visit. Patient phenotype was assessed with the UPOINT system and symptom severity was determined by the National Institutes of Health CPSI. A 6-point decrease in CPSI was used to define patient improvement. Results: A total of 82 patients fit the study criteria. Mean age was 41.6 years (range 19 to 75) and median symptom duration was 24 months (range 3 to 240). Mean CPSI was 26.8 (range 10 to 41), the median number of positive UPOINT domains was 3 (range 1 to 6) and 27 patients (32.9%) were treated locally. At followup 9 patients had refused pelvic floor physical therapy, and 24 and 48 had undergone pelvic floor physical therapy elsewhere and at CCF, respectively. The mean change in CPSI was 1.11 ± 4.1 in patients who refused, −3.46 ± 6.7 in those treated elsewhere and −11.3 ± 7.0 in those treated at CCF (p <0.0001). Individual improvement was seen in 1 patient (11%) who refused, 10 (42%) treated elsewhere and 38 (79.2%) treated at CCF (p <0.0001). On multivariable analysis only physical therapy at CCF (OR 4.23, p = 0.002) and symptom duration (OR 0.52, p = 0.03) predicted improvement. Conclusions: Pelvic floor physical therapy can be effective for chronic pelvic pain syndrome in patients with pelvic floor spasm. However, the outcome depends on specialty training and experience of therapists. References 1 : Quality of life is impaired in men with chronic prostatitis. The Chronic Prostatitis Collaborative Research Network. J Gen Intern Med2001; 16: 656. Google Scholar 2 : Relationship between chronic nonurological associated somatic syndromes and symptom severity in urological chronic pelvic pain syndromes: baseline evaluation of the MAPP Study. J Urol2015; 193: 1254. Link, Google Scholar 3 : Muscle tenderness in men with chronic prostatitis/chronic pelvic pain syndrome: the chronic prostatitis cohort study. J Urol2008; 179: 556. Link, Google Scholar 4 : Integration of myofascial trigger point release and paradoxical relaxation training treatment of chronic pelvic pain in men. J Urol2005; 174: 155. Link, Google Scholar 5 : Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes. Prostate Cancer Prostatic Dis2009; 12: 177. Google Scholar 6 : The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. J Urol1999; 162: 369. Link, Google Scholar 7 : Pelvic floor physical therapy for patients with prostatitis. Curr Urol Rep2000; 1: 155. Google Scholar 8 : Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT. Urology2010; 75: 1249. Google Scholar 9 : Chronic prostatitis/chronic pelvic pain syndrome and pelvic floor spasm: can we diagnose and treat?. Curr Urol Rep2010; 11: 261. Google Scholar 10 : Clinical phenotyping of urologic pain patients. Curr Opin Urol2013; 23: 560. Google Scholar 11 : Classification and treatment of men with chronic prostatitis/chronic pelvic pain syndrome using the UPOINT system. World J Urol2013; 31: 755. Google Scholar 12 : Failure of a monotherapy strategy for difficult chronic prostatitis/chronic pelvic pain syndrome. J Urol2004; 172: 551. Link, Google Scholar 13 : Long-term results of multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome. J Urol2003; 169: 1406. Link, Google Scholar 14 : Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Arch Intern Med2010; 170: 1586. Google Scholar 15 : Pelvic tenderness is not limited to the prostate in chronic prostatitis/chronic pelvic pain syndrome (CPPS) type IIIA and IIIB: comparison of men with and without CP/CPPS. BMC Urol2007; 7: 17. Google Scholar 16 : 6-Day intensive treatment protocol for refractory chronic prostatitis/chronic pelvic pain syndrome using myofascial release and paradoxical relaxation training. J Urol2011; 185: 1294. Link, Google Scholar 17 : Safety and effectiveness of an internal pelvic myofascial trigger point wand for urologic chronic pelvic pain syndrome. Clin J Pain2011; 27: 764. Google Scholar 18 : Predictors of quality of life and pain in chronic prostatitis/chronic pelvic pain syndrome: findings from the National Institutes of Health Chronic Prostatitis Cohort Study. CPCRN Study Group. BJU Int2004; 94: 1279. Google Scholar 19 : Sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: improvement after trigger point release and paradoxical relaxation training. J Urol2006; 176: 1534. Link, Google Scholar 20 : Randomized multicenter feasibility trial of myofascial physical therapy for treatment of urologic chronic pelvic pain syndrome. J Urol2009; 182: 570. Link, Google Scholar 21 : Myofascial trigger points of the pelvic floor: associations with urological pain syndromes and treatment strategies including injection therapy. Curr Urol Rep2013; 14: 409. Google Scholar 22 : Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients. Exp Ther Med2015; 9: 658. Google Scholar © 2015 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited ByKaplan S (2019) Re: Development of a Clinically Relevant Men's Health Phenotype and Correlation of Systemic and Urologic ConditionsJournal of Urology, VOL. 202, NO. 3, (435-436), Online publication date: 1-Sep-2019. Volume 194Issue 4October 2015Page: 1002-1006 Advertisement Copyright & Permissions© 2015 by American Urological Association Education and Research, Inc.Keywordsprostatephysical therapy specialtyprostatitischronic painpelvic floorAcknowledgmentsIna Li provided data management.MetricsAuthor Information Alan Scott Polackwich More articles by this author Jianbo Li More articles by this author Daniel A. Shoskes Financial interest and/or other relationship with Farr Laboratories and Triurol. More articles by this author Expand All Advertisement PDF DownloadLoading ...
Referência(s)